HOME>Investor Relations>Annual Report>Mitsubishi Tanabe Pharma Corporate Report 2019

Mitsubishi Tanabe Pharma Corporate Report

As Mitsubishi Tanabe Pharma became a wholly owned subsidiary of Mitsubishi Chemical Holdings Corporation and its common shares were delisted from the Tokyo Stock Exchange, "Mitsubishi Tanabe Pharma Corporate Report" was discontinued after the 2019 edition. Thank you very much for your support.
We will continue to provide our company information through news releases and web pages.


"Mitsubishi Tanabe Pharma Corporate Report" was selected as one of excellent integrated reports by GPIF's asset managers entrusted with domestic equity investment. For more details, visit the GPIF's website. (February 7, 2020)

Mitsubishi Tanabe Pharma Corporate Report
Corporate Profile

Note) Shigeki Iwane resigned as an Outside Board Director of the Company on October 7, 2019.

Financial Information

ReadSpeaker docReader makes documents accessible to all users including users with vision problems letting users view and listen to texts.
User guide